Pulmonary Fibrosis Treated by Mesenchymal Stem Cells

Monday June 8th, 2009 @ 13:44:53 EST

From Category: Use

Melbourne, Australia -

Systemic administration of stem cells is usually associated with preferential localization into the lung and liver.  Lung conditions such as acute respiratory distress syndrome have no cure with exception of transplantation, which is limited to a small number of patients.  The rationale of using mesenchymal stem cells for pulmonary diseases comes from their ability to inhibit fibrosis, which has been previously reported in liver failure, their ability to differentiate into pulmonary cells, and their capacity to produce growth factors.  Additionally, bone marrow mononuclear cells, which are known to contain both hematopoietic and mesenchymal stem cells have been previously demonstrated to effectively treat an animal model of pulmonary hypertension.

In a recent study (Moodley et al. Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury. Am J Pathol, 2009 Jun 4) the therapeutic ability of Wharton's Jelly derived mesenchymal stem cells was assessed in a lung fibrosis model.

The investigators intravenously administered the mesenchymal stem cells and induced lung injury using the fibrosis-inducing agent bleomycin.  The human mesenchymal stem cells were only detected in areas of injured lungs but not in alveolar tissue that was not damaged.  

Suppression of TGF-beta, IFN-gamma, TNF-alpha, and macrophage chemoattractants was observed locally in the animals treated with the mesenchymal stem cells.

Expression of the TGF-beta effector transcription factor SMAD-2 was also suppressed by the mesenchymal stem cell treatment, whereas matrix metalloprotease 2, which is involved in clearing of fibrotic tissue was upregulated.

The current study supports the possibility of using systemic administration of mesenchymal stem cells for treatment of various fibrotic conditions, however efficacy appears to still require optimization.  Hypothetically one could do this by co-administration of mesenchymal stem cells with agents capable of in vivo activating the cells, for example, estrogen.


Social & Bookmarking:Digg 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to del.icio.us Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Technorati Stumble 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Furl Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Reddit Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Blinklist Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Ma.gnolia Share 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' on Facebook Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Google Add 'Pulmonary Fibrosis Treated by Mesenchymal Stem Cells' to Yahoo Web 

1 Comment | Add Comment

Louly (Alresford) said...

Created 2011-10-05 11:08:57 EST

My brother is severly ill with pulmonary fibrosis.  They have said he is probably too ill to take a transplant.  Can stem cell help him?  Please, I am desperate to find out anything that can help him.  He has four young children.

Can anyone help me.

 Thankyou

Louly 

- 1 -

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2014 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.10